Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	341
Overall Study	STARTED	TOCAS 0.4 mg	327
Overall Study	STARTED	FDC 0.4 mg/6 mg	339
Overall Study	STARTED	FDC 0.4 mg/9 mg	327
Overall Study	Randomized and Treated	Placebo	341
Overall Study	Randomized and Treated	TOCAS 0.4 mg	326
Overall Study	Randomized and Treated	FDC 0.4 mg/6 mg	338
Overall Study	Randomized and Treated	FDC 0.4 mg/9 mg	324
Overall Study	COMPLETED	Placebo	315
Overall Study	COMPLETED	TOCAS 0.4 mg	295
Overall Study	COMPLETED	FDC 0.4 mg/6 mg	299
Overall Study	COMPLETED	FDC 0.4 mg/9 mg	294
Overall Study	NOT COMPLETED	Placebo	26
Overall Study	NOT COMPLETED	TOCAS 0.4 mg	32
Overall Study	NOT COMPLETED	FDC 0.4 mg/6 mg	40
Overall Study	NOT COMPLETED	FDC 0.4 mg/9 mg	33

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01018511/flow